Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: analyst aliu Wed, 02/17/2021 – 11:17 More: Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open
read moreFDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst arlene.weintraub Wed, 02/17/2021 – 10:24 More: FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst Source: fierce
read morePfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns fkansteiner Wed, 02/17/2021 – 09:48 More: Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns Source: fierce
read moreBristol Myers’ Breyanzi tunes its pitch for fight against entrenched CAR-T players Novartis and GIlead esagonowsky Wed, 02/17/2021 – 09:30 More: Bristol Myers' Breyanzi tunes its pitch for fight against entrenched CAR-T players Novartis and GIlead Source: fierce
read moreAstraZeneca’s already dominant Lynparza lines up for early breast cancer with new trial win aliu Wed, 02/17/2021 – 09:22 More: AstraZeneca's already dominant Lynparza lines up for early breast cancer with new trial win Source: fierce
read moreNew data shows overuse of SABA relievers is responsible for 250,000 tonnes of CO2 emissions annually More: Overuse of reliever medication for asthma a ‘major contributor’ to greenhouse gas emissions Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals